Basel, Switzerland
Nutrix AG is a Swiss health-tech startup founded in 2018 that focuses on empowering prevention and extending lifespan through its flagship platform, gSense. This innovative platform utilizes AI, remote monitoring, and data analytics to revolutionize the prevention and management of chronic conditions and mental wellness. Moreover, gSense offers specialized programs for Overweight and Obesity, Type 2 Diabetes, and forthcoming strategies for Chronic Stress and Burnout, Cardiovascular Diseases.
The company has garnered recognition from esteemed platforms such as TechCrunch and has been hailed as one of the Startups to Watch in Switzerland. Notably, it has been listed among the Top Female-Founded Startups in Europe by Sifted. Further, Wired Japan celebrated Nutrix with a prestigious award for its innovative endeavors. Notably, its cutting-edge cortiSense technology secured the CES Innovation Award 2025 in Digital Health, solidifying the company's position as a trailblazer in the health-tech space.
Having garnered considerable attention and accolades, Nutrix AG secured seed investment on 01 July 2024, indicating a positive outlook for the company's growth and market potential. This funding round propels Nutrix AG in realizing its vision of delivering cost-effective prevention and healthcare programs through the amalgamation of AI, wearables, and human care.
Canary Health